已阅读5页,还剩21页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Anticancer Drugs Dr.Qamar Barakzai Department of Pharmacology Ziauddin Medical University Karachi.Pakistan “CANCER” Refers to a Malignant neoplasm (New growth) Cancer cells can manifest: Uncontrolled Proliferation. Loss of function due to lack of ability to differentiate. Invasiveness. The ability to metastasize. Cancer arises as a result of a series of genetic changes in the cell, the main genetic lesions being: Inactivation of tumor suppressor genes. The activation of oncogenes. Antineoplastic agents Are cytotoxic not tumoricidal Only kill cells during mitosis, and Not all cancer cells are dividing at the same time. SUCCESS DEPENDS ON: Stage of cancer at time of diagnosis Type of cancer Development of drug resistance Overall health of patient. R Tumor Suppressor Genes -ve (p53) Growth Factors Oncogenes +ve S DNA Synthesis G2 Premitotic Interval M PROPHASE METAPHASE ANAPHASE TELOPHASE MITOSIS G0G1 S PHASE SPECIFIC Cytosine Arbinoside Hydroxyurea S PHASE SPECIFIC SELF LIMITING 6-Mercaptpurine Methotrexate. M PHASE SPECIFIC vincristine vinblastine paclitaxel PHASE NONSPECIFIC alkylating agents, cis-platinum nitrosoureas, dacarbazine antibiotics procarbazine G0 Differentiation CELL GROWTH CYCLE 5 DISTINCT PHASES OF MITOSIS 1. G0 - Resting - no mitosis 2. G1 - Postmitotic - first growth 3. S - DNA synthesis phase 4. G2 - Premitotic - second growth 5. M - Mitosis phase GENERATION TIME - one complete cycle different in all tumors, from hours to days PENTOSTATIN Inhibits adenosine Deaminase PALA Inhibits Pyrimidine Biosynthesis Purine synthesis Pyrimidine synthesis Ribonucleotides Deoxyribonucleotides DNA HYDROXYUREA Inhibit Ribonucleotide Reductase 6-MERCAPTOPURINE 6-THIOGAUNINE Inhibit Puring ring biosynthesis Inhibit Neocleotide interconversions 5-FLOUROURACIL Inhibit TMP Synthesis METHOTREXATE Inhibit dihydrofolate reduction, blocks TMP and Purine synthesis DNA RNA (Transfer, messenger, ribosomal) CYTARABINE FLUDARABINE 2-CHLORODEOXY ADENOSINE Inhibit DNA Synthesis ALKYLATING AGENTS MITOMYCETIN CISPLATIN PROCARBAZINE DACARBAZINE Form adducts w/ DNA BLEOMYCIN ETOPOSIDE TENIPOSIDE Damage DNA and Prevent repair DACTINOMYCINE DAUNORUBICIN DOXORUBICIN MITOXANTRONE Intercalate with DNA Inhibit RNA synthesis PROTEINS Enzymes Microtubules A-ASPARAGINASEDeaminate asparagine Inhibits protein synthesis PACLITAXEL VINCA ALKALOIDS COLCHICINE Inhibit function of Microtubules ANTINEOPLASTIC AGENTS DEFINITIONS: ALKYLATION - chemical reaction that cleaves DNA and interferes with mitosis BIFUNCTIONAL ALKYLATING AGENTS - have 2 alkyl groups and alkalate 2 DNA strands DOSE-LIMITED SIDE EFFECTS - adverse effects that prevent an agent from being given in higher doses EMETIC POTENTIAL - potential of an agent to cause N & V ANTINEOPLASTIC AGENTS ADVERSE EFFECTS: Kills all fast growing cells Hair follicles GI tract mucosa Bone marrow suppression (BMS) causing anemiaand leukopenia All are pregnancy category D ! Most are nephro- hepato- and ototoxic Extravasation of IV can result in loss of limb Antineoplastic Agents ADVERSE EFFECTS: (Contd) All have a BMS and emetic index All have wide interaction with other drugs. Special training required for nursing Most agents can be harmful to nurse administering them DEFINITIONS: GROWTH FRACTION % of cells in mitosis at any given time LEUCOVORIN RESCUE - use of leucovorin to reverse methotrexate-induced toxicity MITOTIC INDEX number of cells per unit undergoing mitosis during a given time NADIR lowest point (as in blood count) after being depressed by chemotherapy PARANEOPLASTIC SYNDROME (PNS) S/S of cancer located distant from tumor or its metastatic sites ANTINEOPLASTIC AGENTS 2 MAIN GROUPS OF AGENTS: CELL CYCLE - NONSPECIFIC (CCNS) ALKYLATING AGENTS cytotoxic in any phase of cell cycle effective against slowly growing tumors CELL CYCLE - SPECIFIC (CCS) 3 TYPES ANTIMETABOLITES - cytotoxic is S phase MITOTIC INHIBITORS - cytotoxic in M phase CYTOTOXIC ANTIBIOTICS (some are CCNS) effective against rapidly growing tumors ALKYLATING AGENTS NITROGEN MUSTARDS first developed in 1940s CCNS killing ability mechlorethamine is the prototypical agent USES: Hodgkins disease & lymphomas. leukemias, CANCERS OF lung, breast, ovary, testes, brain, bladder, Most widely used agent, often in combination with other agents. ALKYLATING AGENTS SELECTED AGENTS: Mechlorethamine (Mustine, Mustargen) IV only (adult use only) Cyclophosphamide (Cytoxan, Neosar) IV and PO, adults and pediatric use Carmustine (BiCNU) IV, adult only, can cross blood-brain barrier, therefore used to tread brain lesions OTHER AGENTS: Chlorambucil, Streptozotocin Hepatic cytochrome P450 0xidase 4-Hydroxycyclophosphamide Aldophosphamide Enzymatic Non enzymatic Hepatic aldehyde oxidase 4-Ketocyclophosphamide (Inactive). Acrolein Cytotoxic Phosphamide Mustard Cytotoxic. Carboxyphosphamide (Inactive). Responsible for unwanted effects Cyclophosphamide (Inactive) Cyclophosphamide (Inactive) Hepatic cytochrome P450 0xidase 4-Hydroxycyclophosphamide Aldophosphamide Enzymatic Non enzymatic Hepatic aldehyde oxidase 4-Ketocyclophosphamide (Inactive). Acrolein Cytotoxic Phosphamide Mustard Cytotoxic Carboxyphosphamide (Inactive). Responsible for unwanted effects ANTIMETABOLITES ACTIONS: Antagonism of folate, purines, and pyrimidines needed for synthesis of nucleic acids - stops cell replication USES: Solid tumors (breast, lung, liver, brain, colon. Stomach, pancreas) Lymphomas, leukemias. Some agents also immunosuppressive, Useful in treating immune-mediated diseases ANTIMETABOLITES SELECTED AGENTS: (FOLIC ACID ANALOG) METHOTREXATE (Folex, Rheumatrex, MTx) Folic acid antagonist PO & IM, adult and pediatric use Also used to treat immune-mediated diseases, Used incombination with misoprostol for therapeutic abortion Causes profound anemia (folate depletion) Therefore leucovorin “rescue” often used to counteract ANTIMETABOLITES SELECTED AGENTS: PURINE ANALOG - MERCAPTOPURINE (6-MP, Purinethol) - Purine antagonist - PO only, adult and pediatric use PYRIMIDINE ANALOG - CYTARABINE (Ara-C, Cytosar-U) -Pyrimidine antagonist -IV and intrathecal (within spinal canal) MITOTIC INHIBITORS ACTIONS: Plant alkaloids (periwinkle, yew tree, mandrake plant, etc.) Bind to and disrupt mitotic spindles USES: Lymphomas (Hodgkins and non-Hodgkins), Neuroblastoma Kaposis sarcoma, Solid tumors (breast, testicular, etc.) MITOTIC INHIBITORS SELECTED AGENTS: ETOPOSIDE (VP-16, VePesid) IV and PO, adult use only PACLITAZEL (Taxol) IV only, adult use only drug of choice for ovary and breast ca VINCRISTINE (LCR, VCR,Oncovin) IV only, adult and pediatric use drug of choice for acute leukemia CYTOTOXIC ANTIBIOTICS ACTIONS: Source: Streptomyces mold - work by intercalation (insertion of drug molecule between the 2 DNA strands causing it to (“unwind”) Kill some bacteria and viruses but are too toxic to use for infections IV extravasation constant danger ! USES: wide variety of solid tumors, always used in combination with other agents CYTOTOXIC ANTIBIOTICS SELECTED AGENTS: DOXORUBICIN (ADR, Rubex, Doxil) IV only, adult use only BLEOMYCIN (BLM, Blenoxane) IM, IV, SQ, adult use only very toxic agents ! MISCELLANEOUS ANTINEOPLASTICS Various actions, Both CCNS and CCS Used in comb
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 开发银行财务会计题库及解析
- 口呼吸改善建议基于自我测试结果的分析
- 积极心态塑造自我测试题与答案详解
- 开店项目测试题及答案大全
- 经济学家心算技巧教程与答案解析
- 建筑工程技术质量监理考试题库及解析
- 工业相机测试操作试题及参考答案
- T∕HNSBSXH 09-2025 球孢白僵菌与引诱剂联用控制瓜实蝇的技术规程
- 德语学习自测题及答案集
- 康复悬吊测试题库及备考指南
- 人文成都智慧树知到期末考试答案章节答案2024年成都师范学院
- 研学旅行主题活动设计案例
- (高清版)DZT 0142-2010 航空磁测技术规范
- 《因果推断实用计量方法》大学教学课件-双重差分法
- 无期限的六合公式汇编
- 先张法预应力混凝土管桩基础技术规程
- G50058爆炸危险环境电力装置设计规范新老对比
- 2023年光器件工艺工程师年终总结及下一年展望
- 催化裂化-认识催化裂化(石油加工课件)
- 气管切开换药的护理操作程序(图解)
- ISO 22000-2018食品质量管理体系-食品链中各类组织的要求(2023-雷泽佳译)
评论
0/150
提交评论